Lords Mark promoter proposes reinvesting ₹76.18 crore sale proceeds in med devices
- Promoter Sachidanand Hariram Upadhyay sold 89,98,598 equity shares for net proceeds of ₹76.18 crore
- Stake reduced from 75.11% to 73.00% following open market transaction on September 29, 2026
- Promoter proposes reinvesting majority of proceeds into medical device unit expansion
- Transaction disclosed under SEBI Listing Regulations, confirming funds credited to bank account
*this image is generated using AI for illustrative purposes only.
Lords Mark Industries Limited promoter Sachidanand Hariram Upadhyay has proposed to reinvest the majority of proceeds from his recent share sale towards the strategic expansion of the company's medical device unit. The promoter sold 89,98,598 equity shares on September 29, 2026, generating net proceeds of ₹76,18,19,624.
This development follows the initial disclosure of the stake reduction under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The confirmation letter dated October 1, 2026, clarifies that the funds were credited to the promoter's bank account and outlines the intent to channel these resources back into the business through viable means.
Transaction details
The promoter group member executed the disposal exclusively through the open market mechanism on the BSE. No encumbrances such as pledges or liens were associated with the shares prior to or after the sale. The total diluted share capital remained unchanged as no convertible securities were involved.
| Metric | Before Sale | After Sale | Change |
|---|---|---|---|
| Shares held | 32,04,39,246 | 31,14,40,648 | -89,98,598 |
| Holding (%) | 75.11% | 73.00% | -2.11% |
| Net Proceeds (₹) | N/A | N/A | 76,18,19,624 |
Capital structure context
The company's total equity share capital consists of 42,66,22,217 equity shares of ₹10 each, aggregating to ₹426,62,22,170. This capital structure remains constant before and after the promoter's sale, as the transaction involved existing shares rather than new issuance. Following this sale, Upadhyay's holding stands at 31,14,40,648 shares, or 73.00% of the total voting capital. The disclosure was made under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, and Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.
What the numbers show
The proposal to reinvest the majority of the ₹76.18 crore net proceeds signals a commitment to internal growth rather than personal liquidity extraction. While the promoter's stake decreased from 75.11% to 73.00%, maintaining a substantial majority above the 50% threshold for absolute control, the redirection of capital into the medical device unit suggests a strategic pivot or acceleration in that specific segment. The retention of 73% ownership ensures continued promoter influence over corporate decisions while leveraging external market liquidity for operational expansion.
Historical Stock Returns for Lords Mark Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -5.00% | -5.36% | -15.62% | 0.0% | 0.0% | 0.0% |
What specific medical device product lines or technologies will the ₹76.18 crore reinvestment primarily target for expansion?
How does this capital injection into the medical device unit align with Lords Mark Industries' long-term revenue diversification strategy away from its core industrial segments?
Will the promoter's reduced stake to 73% trigger any changes in board composition or governance structures to accommodate new institutional investors?
17
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
